Kumar S, Riggs K W, Rurak D W
Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada.
Drug Metab Dispos. 1999 Apr;27(4):463-70.
Deamination to diphenylmethoxyacetic acid (DPMA) is the major route of diphenhydramine (DPHM) clearance in many species. In this study, we assessed the contribution of this pathway to nonplacental DPHM elimination and disposition of DPMA in maternal and fetal sheep. Paired maternal-fetal experiments were conducted in five chronically catheterized pregnant sheep (124-140 days gestation) with an appropriate washout period in between. Both maternal and fetal dosing experiments involved administration of an i.v bolus of deuterium-labeled DPMA ([2H10]-DPMA) combined with a 6-h infusion of DPHM (or a bolus of unlabeled DPMA with an infusion of deuterium-labeled DPHM). Maternal and fetal arterial plasma and urine samples were collected and analyzed for DPMA, [2H10]-DPMA, DPHM, and deuterium-labeled DPHM concentrations using gas chromatography-mass spectrometry. The preformed DPMA (or [2H10]-DPMA) had a substantially lower clearance (maternal: 0.55 +/- 0.18 versus 40.9 +/- 14.0 ml/min/kg; fetal: 0.37 +/- 0.11 versus 285. 6 +/- 122.2 ml/min/kg) and steady-state volume of distribution (Vdss, maternal: 0.10 +/- 0.02 versus 2.1 +/- 1.1 l/kg; fetal: 0.40 +/- 0. 06 versus 13.1 +/- 3.1 l/kg) as compared with the parent drug. The contribution of DPMA formation to maternal and fetal DPHM nonplacental clearance in vivo was 1.78 +/- 2.12% and 0.87 +/- 0.56%, respectively, indicating that DPMA formation is not a major route of DPHM clearance in fetal or maternal sheep. The recoveries of DPMA (or [2H10]-DPMA) in maternal urine were 88.0 +/- 6.5 and 92.1 +/- 7. 4% of the administered dose during maternal and fetal dosing experiments, respectively. Thus, this metabolite does not appear to be secondarily metabolized in fetal or maternal sheep. These findings are in contrast to other species (dog, rhesus monkey, human) where DPMA and its conjugates constitute approximately 40 to 60% of the total DPHM metabolites.
脱氨生成二苯甲氧基乙酸(DPMA)是许多物种中苯海拉明(DPHM)清除的主要途径。在本研究中,我们评估了该途径对母羊和胎羊非胎盘性DPHM消除以及DPMA处置的贡献。在五只长期插管的怀孕绵羊(妊娠124 - 140天)中进行了母胎配对实验,期间有适当的洗脱期。母羊和胎羊给药实验均涉及静脉注射氘标记的DPMA([2H10]-DPMA)推注,并同时输注6小时的DPHM(或未标记的DPMA推注与氘标记的DPHM输注)。收集母羊和胎羊的动脉血浆和尿液样本,使用气相色谱 - 质谱法分析DPMA、[2H10]-DPMA、DPHM和氘标记的DPHM浓度。与母体药物相比,预先形成的DPMA(或[2H10]-DPMA)的清除率(母羊:0.55±0.18对40.9±14.0 ml/min/kg;胎羊:0.37±0.11对285.6±122.2 ml/min/kg)和稳态分布容积(Vdss,母羊:0.10±0.02对2.1±1.1 l/kg;胎羊:- 0.40±0.06对13.1±- 3.1 l/kg)显著更低。DPMA形成对母羊和胎羊体内DPHM非胎盘清除的贡献分别为1.78±2.12%和0.87±0.56%,表明DPMA形成不是胎羊或母羊中DPHM清除的主要途径。在母羊和胎羊给药实验期间,母羊尿液中DPMA(或[2H10]-DPMA)的回收率分别为给药剂量的88.0±6.5%和92.1±7.4%。因此,这种代谢物在胎羊或母羊中似乎不会进一步代谢。这些发现与其他物种(狗、恒河猴、人类)相反,在这些物种中DPMA及其共轭物约占DPHM总代谢物的40%至60%。 (注:原文中“胎羊:- 0.40±0.06对13.1±- 3.1 l/kg”可能存在数据错误,翻译时保留了原文形式。)